Please join us for a PMC and MIT Center for Biomedical Innovation Forum

Personalized Medicine and CNS Disorders: The Changing Landscape of Mental and Neurological Illness

Thursday, August 17, 2006
1:00 p.m. - 5:00 p.m.
Cambridge, MA

This half-day seminar will explore how new diagnostic tools are changing psychotropic and neurological drug discovery and development and the impact on patients with CNS (Central Nervous System) disorders.

This forum will explore how personalized medicine is changing the landscape of mental and neurological illnesses from the points of view of the pharmaceutical industry, diagnostic companies, practicing clinicians, government regulators, and insurance companies.

The forum will feature two sessions focusing on CNS drugs and pharmaceutical R&D, in addition to how personalized medicine is transforming the practice of neurology and psychiatry.

Click here to view program information and presentation details.

Speakers Include:

Frank Douglas, M.D., Ph.D.
MIT Center for Biomedical Innovation

Stephen Furlong, Ph.D.
AstraZeneca

Eiry W. Roberts, MB (Hons) BS, BSc MRCP, AFPM
Eli Lilly and Company

Gualberto Ruano, M.D., Ph.D.
Genomas

Evian Gordon, M.D., Ph.D.
The Brain Resource Company

Scott Rauch, M.D.
Massachusetts General Hospital

David Whitehouse, M.D.
United Behavioral Health

This seminar follows a morning session:
Vaccines: Opportunities and Barriers Across the Value Chain. (Click here to view the agenda)

This event is being held as part of the 5th Annual Celebration of Biotechnology in Kendall Square, an evening celebrating one of the most concentrated biotechnology clusters in the world.

The Personalized Medicine Coalition, representing a broad spectrum of academic, industrial, patient, provider, and payer communities, seeks to advance the understanding and adoption of personalized medicine concepts and products for the benefit of patients. For more information please visit www.personalizedmedicinecoalition.org.